XML 19 R3.htm IDEA: XBRL DOCUMENT v3.25.4
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2025
Dec. 31, 2024
Current assets    
Cash and cash equivalents $ 4,360 $ 16,856
Restricted cash 595 958
Property and equipment, held for sale 157
Other current assets 463 2,706
Total current assets 5,575 20,520
Non-current assets    
Non-current restricted cash 161
Operating lease right-of-use assets 5,457
Property and equipment, net 5,045
In-process Research and development (“IPR&D”) asset 208 12,050
Total non-current assets 208 22,713
Total Assets 5,783 43,233
Current liabilities    
Trade account payables 3,120 1,882
Current portion of lease liabilities 1,436 1,130
Other account payables 1,823 5,255
Total current liabilities 6,379 8,267
Non-current liabilities    
Operating lease liabilities, net of current portion 8,454
Other liabilities 77
Warrants 706 2,287
Total non-current liabilities 706 10,818
Commitments and Contingencies (Note 8)
Stockholders’ equity (capital deficiency)    
Preferred Stock, $0.0001 par value; Authorized - 1,000,000 shares as of December 31, 2025 and December 31, 2024. Issued and outstanding – 147,512 as of December 31, 2025 and 147,735 shares as of December 31, 2024. 18,617 18,645
Common stock, $0.0001 par value (“Common Stock”); Authorized - 750,000,000 shares as of December 31, 2025 and December 31, 2024. Issued and outstanding – 1,593,703 and 1,023,010 as of December 31, 2025 and December 31, 2024, respectively. (*) [1] 7 6
Additional paid in capital 196,970 186,194
Accumulated deficit (216,896) (180,697)
Total Stockholders’ equity (capital deficiency) (1,302) 24,148
Total liabilities and stockholders’ equity $ 5,783 $ 43,233
[1] All share amounts have been retroactively adjusted to reflect a 1-for-19 reverse share split as discussed in Note 12A.